Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Oxidation-reduction Homeostasis on Cognitive Impairment in Patients With Ischemic Stroke

NCT03519828 is registered in ClinicalTrials.gov with Hui-Sheng Chen as lead sponsor.

NCT NCT03519828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03519828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Oxidation-reduction Homeostasis on Cognitive Impairment in Patients With Ischemic Stroke
Lead sponsor
Hui-Sheng Chen
Phase
Observational
Overall status
Completed
Start date
March 1, 2018
Completion date
January 1, 2019
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oxidative-reduction homeostasis, post-stroke cognitive impairment